SAB Biotherapeutics, Inc. announced the appointment of Rear Admiral (RADM), retired, Scott Giberson, a former Assistant U.S. Surgeon General and two-star admiral with the U.S.Public Health Service to SAB's Board of Directors, effective July 7, 2022. RADM Giberson retired after a decorated career and 27 years of service. Currently, RADM (ret.) Giberson is the President of AMI Expeditionary Healthcare, a company that provides medical services to international aid organizations, humanitarian concerns, the private sector and government agencies in a wide range of remote and challenging environments.

RADM (ret.) Giberson served as the acting Deputy Surgeon General of the United States (2013-2014), where he worked with the U.S. Surgeon General to develop and deliver scientific information to the public. In that role, he served as the Surgeon General's principal liaison with health leadership in the Department of Defense, Department of Homeland Security, and Department of Health and Human Services, among others. He held additional executive positions as the Senior Advisor to the Office of Surgeon General, Director of Commissioned Corps Headquarters, Chief Pharmacist of the U. S. Public Health Service, and Senior Public Health Advisor for Pacific Command's Center of Excellence in Disaster Management and Humanitarian Assistance.

In 2014, he also served as overall Commander of the Commissioned Corps' Ebola Response in West Africa.